Back

MRI-based assessment of cardiac safety of pirtobrutinib in chronic lymphocytic leukaemia

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Coronary disease and cardiovascular toxicity in patients with cancer Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Olivier Clerc

Mass General Brigham, Boston (United States of America)

Photo
Doctor Sarah Cuddy

Brigham and Women's Hospital, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Liraglutide reduces myocardial metalloproteinase 2 activity without attenuating doxorubicin-induced cardiac dysfunction in rats
Doctor C. Rodrigues Tonon (Botucatu, BR)
Abstract Slides Video
Presentation thumbnail
Cancer-specific mortality after acute coronary syndrome: insights from a nationwide real-world cohort
Miss M. Li (Suzhou, CN)
Abstract Slides Video
Presentation thumbnail
Cardiovascular adverse events in newly diagnosed multiple myeloma: incidence, predictors, and prognostic impact
Professor D. Zhao (Dalian, CN)
Presentation thumbnail
Construction and validation of a nomogram prediction model for myocardial injury in breast cancer patients after treatment
Professor Y. Zhang (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Residual cardiovascular risk after ACS in oncologic patients: the prognostic role of persistently elevated NT proBNP.
Doctor A. Denegri (Parma, IT) Doctor F. Wenzl (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary disease and cardiovascular toxicity in patients with cancer

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular safety of next-generation BTK inhibitors versus ibrutinib in CLL/SLL: a systematic review and meta-analysis of randomised controlled trials
31 August 2026
thumbnail
Congress Presentation
The role of cardiac magnetic resonance
20 June 2025
thumbnail
Congress Presentation
Inhibition of B cell activation by Ibrutinib improves cardiac function in experimental myocardial infarction in mice
1 September 2024
thumbnail
Congress Presentation
Cell painting based high-content phenotypic screening to elucidate kinase signaling pathways in ibrutinib-mediated atrial fibrillation
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources